Current status of common chronic diseases and comorbidities among people aged ≥15 years in Urumqi
10.3969/j.issn.1006-2483.2025.06.019
- VernacularTitle:乌鲁木齐市≥15岁人群常见慢性病及共患病现况研究
- Author:
Yiran ZHOU
1
;
Aiken GULIJIAYINA
1
;
Yaoqin LU
2
Author Information
1. School of Public Health, Xinjiang Medical University, Urumqi , Xinjiang 830054, China
2. School of Public Health, Xinjiang Medical University, Urumqi , Xinjiang 830054, China;Urumqi Center for Disease Control and Prevention, Urumqi , Xinjiang 830022, China
- Publication Type:Journal Article
- Keywords:
Chronic disease;
Comorbidity;
Prevalence study
- From:
Journal of Public Health and Preventive Medicine
2025;36(6):81-85
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the prevalence of common chronic diseases and comorbidities among people aged ≥15 years in Urumqi, and to provide a theoretical basis for the prevention and treatment of chronic diseases in the region. Methods Using population health surveillance data from 2016 to 2021, a retrospective analysis was performed on the prevalence of 15 chronic diseases among permanent residents aged 15 years and above in Urumqi. Results From 2016 to 2021, the detection rate of common chronic diseases among people aged 15 years or above in Urumqi was higher among the female, urban, ≥65 years, and overweight and obese populations. Among the 15 prevalent chronic diseases, dyslipidemia (fatty liver) had the highest detection rate, while hypertension, diabetes mellitus, cholecystitis, and coronary heart disease (myocardial infarction) ranked second to fifth, in common chronic disease detection rates. The prevalence of comorbidities among patients with chronic diseases was consistent with that of chronic diseases, with the overall prevalence of women being higher than that of men (χ2=127.31, P<0.001), and the prevalence in urban areas being higher than that in rural areas (χ2=16503.75, P <0. 001). The prevalence of comorbidities increased gradually with age (χ2=9179.36, P <0.001). The proportion of people with comorbidities who had abnormal BMI was significantly higher than that of people with normal BMI (χ2=21699.61, P <0.001). The proportion of chronic disease patients with single diseases increased gradually from 2016 to 2020 and decreased significantly by 2021, while the proportion of patients with comorbidities increased significantly by 2021. The number of comorbidity disease types in the study population showed an increasing trend year by year with age. Conclusion The detection rate of chronic diseases among people over 15 years old is high in Urumqi, and there is an increasing prevalence of comorbidities in patients. Chronic diseases, mainly dyslipidemia (fatty liver), hypertension, diabetes, cholecystitis and coronary heart disease (myocardial infarction) are highly prevalent. These findings indicate the need for the development of comprehensive prevention and treatment intervention measures.
